サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1478704

脂質ナノ粒子原料市場、シェア、規模、動向、産業分析レポート：製品別、適応疾患別、用途別、最終用途別、地域別、セグメント予測、2024年～2032年

Lipid Nanoparticle Raw Materials Market Share, Size, Trends, Industry Analysis Report, By Product (Ionizable lipids, Reagents, Other raw materials); By Disease Indication; By Application; By End-use; By Region; Segment Forecast, 2024 - 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 114 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.64円
脂質ナノ粒子原料市場、シェア、規模、動向、産業分析レポート：製品別、適応疾患別、用途別、最終用途別、地域別、セグメント予測、2024年～2032年
出版日: 2024年04月24日
発行: Polaris Market Research
ページ情報: 英文 114 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Researchの最新調査によると、脂質ナノ粒子原料の世界市場規模は2032年までに3億3,385万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

脂質ナノ粒子原料に対する需要の高まりは、ワクチン接種開発への注目の高まりに大きく起因しています。世界の人口は慢性的な健康問題、特にがんや血液適応疾患の著しい急増を目の当たりにしています。このため、医療研究者は市場で効果的な診断と治療手順を策定する必要に迫られており、脂質ナノ粒子原料のニーズが大幅に促進されることになります。例えば、2023年10月、生物医療研究所の研究者は、大腸炎関連がんのための経口液体ナノ粒子薬の開発を発表しました。

新たな研究機関の開拓の増加は、世界の脂質ナノ粒子原料市場に最適な影響を与えています。例えば、2023年9月、Centre for Process Innovationは英国にCenter of Excellence RNAを導入し、臨床試験用の脂質ナノ粒子とRNAの生産を目指しています。さらに、科学開発を促進するための政府による投資や助成金の増加は、特に不十分なワクチンの問題に対処するために、長期的には脂質ナノ粒子の生産をさらに促進すると考えられます。例えば、2023年9月、Centre of Excellence RNAは、RNAの生産と開発活動で企業を支援するため、2,600万英ポンドの資金提供を受けた。

さらに、現在進行中の製品上市は、ワクチン、細胞と遺伝子治療の製造のための脂質ナノ粒子の開発の進歩を支えています。例えば、2024年4月、Cayman Chemicalsは脂質ナノ粒子を発見する可能性のあるLipidLaunch研究ツールを発表しました。研究の革新が進むことで、脂質ナノ粒子の真の可能性が解明され、調査期間中の市場成長が促進される可能性が高いです。例えば、Nature Communication誌に掲載された2024年の研究では、ナノ粒子を使用した標的肺キャリアシステムが開発されました。

さらに、脂質ナノ粒子の生産能力を向上させるために研究者によって取られた努力の高まりは、脂質ナノ粒子原料市場の成長を促進する可能性が高いです。例えば、2023年8月、研究者は、脂質ナノ粒子ワクチン（SARS-CoV-2 mRNA）の高い生産率を可能にする新しいプラットフォームの発売を発表しました。

脂質ナノ粒子原料市場レポートハイライト

キットセグメントは、手頃な価格と研究活動の柔軟性から、最も高い成長が見込まれます。

感染症セグメントは、感染症による健康問題の増加により、最大の市場シェアを占める。

治療セグメントは、治療法の開発が進んでいることから、より大きな収益シェアを占めると予測されます。

アジア太平洋は、予測期間中に最も速い成長を記録すると予測されています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の脂質ナノ粒子原料市場洞察

  • 用途スナップショット
  • 脂質ナノ粒子原料市場力学
    • 促進要因と機会
      • 肺適応疾患の発生率上昇
      • 複数の治療製剤におけるmRNA技術の採用増加
    • 抑制要因と課題
      • 複雑な生産プロセスが市場の成長を妨げる可能性がある
  • PESTEL分析
  • 脂質ナノ粒子原料市場の応用動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界の脂質ナノ粒子原料市場：適応疾患別

  • 主要調査結果
  • イントロダクション
  • がん
  • 感染症
  • 血液適応疾患
  • その他

第6章 世界の脂質ナノ粒子原料市場：製品別

  • 主要調査結果
  • イントロダクション
  • キット
  • 試薬
  • その他

第7章 世界の脂質ナノ粒子原料市場：用途別

  • 主要調査結果
  • イントロダクション
  • 治療
  • 研究

第8章 世界の脂質ナノ粒子原料市場：地域別

  • 主要調査結果
  • イントロダクション
    • 脂質ナノ粒子原料市場評価：地域別、2019～2032年
  • 北米
    • 北米：適応疾患別、2019～2032年
    • 北米：用途別、2019～2032年
    • 北米：製品別、2019～2032年
    • 米国
    • カナダ
  • 欧州
    • 欧州：適応疾患別、2019～2032年
    • 欧州：用途別、2019～2032年
    • 欧州：製品別、2019～2032年
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
  • アジア太平洋
    • アジア太平洋：適応疾患別、2019～2032年
    • アジア太平洋：用途別、2019～2032年
    • アジア太平洋：製品別、2019～2032年
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
  • 中東・アフリカ
    • 中東・アフリカ：疾病別、2019～2032年
    • 中東・アフリカ：用途別、2019～2032年
    • 中東・アフリカ：製品別、2019～2032年
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
  • ラテンアメリカ
    • ラテンアメリカ：疾病別、2019～2032年
    • ラテンアメリカ：用途別、2019～2032年
    • ラテンアメリカ：製品別、2019～2032年
    • メキシコ
    • ブラジル
    • アルゼンチン

第9章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Avanti Polar Lipids（米国）
  • .Biopharma PEG Scientific Inc.（米国）
  • BroadPharm（米国）
  • CordenPharma International（ドイツ）
  • Creative Biolabs（米国）
  • Echelon Biosciences（米国）
  • Merck KGaA（ドイツ）
  • NOF AMERICA CORPORATION（米国）
  • Polysciences, Inc.（米国）
  • Tebu Bio（フランス）
図表

List of Tables

  • Table 1 Global Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 2 Global Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 3 Global Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 4 Lipid Nanoparticle Raw Materials Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 6 North America: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 7 North America: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 8 U.S.: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 9 U.S.: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 10 U.S.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 11 Canada: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 12 Canada: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 13 Canada: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 14 Europe: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 15 Europe: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 16 Europe: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 17 UK: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 18 UK: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 19 UK: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 20 France: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 21 France: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 22 France: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 23 Germany: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 24 Germany: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 25 Germany: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 26 Italy: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 27 Italy: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 28 Italy: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 29 Spain: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 30 Spain: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 31 Spain: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 32 Netherlands: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 33 Netherlands: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 34 Netherlands: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 35 Russia: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 36 Russia: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 37 Russia: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 41 China: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 42 China: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 43 China: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 44 India: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 45 India: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 46 India: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 47 Malaysia: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 48 Malaysia: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 49 Malaysia: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 50 Japan: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 51 Japan: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 52 Japan: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 53 Indonesia: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 54 Indonesia: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 55 Indonesia: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 56 South Korea: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 57 South Korea: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 58 South Korea: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 65 UAE: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 66 UAE: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 67 UAE: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 68 Israel: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 69 Israel: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 70 Israel: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 71 South Africa: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 72 South Africa: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 73 South Africa: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 74 Latin America: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 75 Latin America: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 76 Latin America: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 77 Mexico: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 78 Mexico: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 79 Mexico: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 80 Brazil: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 81 Brazil: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 82 Brazil: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 83 Argentina: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 84 Argentina: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 85 Argentina: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Lipid Nanoparticle Raw Materials Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Lipid Nanoparticle Raw Materials Market, by Product, 2022 & 2032 (USD Million)
  • Figure 8. Market by Disease Indication
  • Figure 9. Global Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2022 & 2032 (USD Million)
  • Figure 10. Market by Application
  • Figure 11. Global Lipid Nanoparticle Raw Materials Market, by Application , 2022 & 2032 (USD Million)
  • Figure 12. Lipid Nanoparticle Raw Materials Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Lipid Nanoparticle Raw Materials Market
目次
Product Code: PM4891

The global lipid nanoparticle raw materials market size is expected to reach USD 333.85 million by 2032, according to a new study by Polaris Market Research. The report "Lipid Nanoparticle Raw Materials Market Share, Size, Trends, Industry Analysis Report, By Product (Ionizable lipids, Reagents, Other raw materials); By Disease Indication; By Application; By End-use; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising demand for the lipid nanoparticle raw materials is highly attributable to the increasing focus on vaccination development. The worldwide population is witnessing a significant surge in chronic health issues, specifically cancer and blood diseases. This is enforcing healthcare researchers to formulate effective diagnosis and treatment procedures in the marketplace, which will significantly facilitate the need for lipid nanoparticle raw materials. For instance, in October 2023, the researchers at the Institute for Biomedical Science announced the development of an oral liquid nanoparticle drug for colitis-associated cancer.

The increasing development of new research institutes is optimally influencing the global lipid nanoparticle raw material market. For instance, in September 2023, Centre for Process Innovation introduced the Center of Excellence RNA in the UK, aiming to produce lipid nanoparticles and RNA for clinical trials. Additionally, the rising investments and grants by the government to fuel scientific developments, specifically to address the problem of inadequate vaccines, will further fuel the production of lipid nanoparticles in the long run. For instance, in September 2023, the RNA Centre of Excellence received funding of GBP 26 million to assist companies in the production and development activities of RNA.

Furthermore, the ongoing product launches are supporting advancements in the development of lipid nanoparticles for the manufacturing of vaccines, cell and gene therapies. For instance, in April 2024, Cayman Chemicals introduced the LipidLaunch research tools that have the potential to discover lipid nanoparticles. The growing research innovations unravel the true potential of the lipid nanoparticles, which will likely drive market growth during the study period. For instance, a 2024 study published in Nature Communication developed the targeted lung carrier system with the use of nanoparticles.

Additionally, the rising efforts taken by the researchers to increase the production capacity of lipid nanoparticles are likely to drive the growth of the lipid nanoparticle raw material market. For instance, in August 2023, researchers unveiled the launch of a new platform that enables a higher rate of production of lipid nanoparticle vaccines (SARS-CoV-2 mRNA).

Lipid Nanoparticle Raw Materials Market Report Highlights

Kits segment is anticipated to witness the highest growth due to its affordability and flexibility in research activities.

Infectious disease segment accounted for the largest market share owing to the increasing number of health issues due to infections.

Therapeutics segment is projected to experience a larger revenue share due to the growing development of therapies.

APAC is projected to register the fastest growth during the forecast period, attributable to the increasing blood cancer rate in the region.

The global players include Avanti Polar Lipids, Biopharma PEG Scientific Inc., BroadPharm, CordenPharma International, Creative Biolabs, & Echelon Biosciences.

Polaris Market Research has segmented the lipid nanoparticle raw materials market report based on product, disease indication, application, end-use, and region:

Lipid Nanoparticle Raw Materials, Product Outlook (Revenue - USD Million, 2019 - 2032)

  • Ionizable lipids
  • PEGylated lipids
  • Sterol lipids
  • Neutral phospholipids
  • Kits
  • Reagents
  • Other raw materials

Lipid Nanoparticle Raw Materials, Disease Indication Outlook (Revenue - USD Million, 2019 - 2032)

  • Cancer
  • Infectious Diseases
  • Blood Diseases
  • Others

Lipid Nanoparticle Raw Materials, Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Therapeutics
  • Research

Lipid Nanoparticle Raw Materials, End-use Outlook (Revenue - USD Million, 2019 - 2032)

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Others

Lipid Nanoparticle Raw Materials, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Lipid Nanoparticle Raw Materials Market Insights

  • 4.1. Lipid Nanoparticle Raw Materials Market - Application Snapshot
  • 4.2. Lipid Nanoparticle Raw Materials Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising incidence of lung diseases
      • 4.2.1.2. Increasing adoption of mRNA technology in multiple therapeutic formulations
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Complex production process is likely to impede market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Lipid Nanoparticle Raw Materials Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Lipid Nanoparticle Raw Materials Market, by Disease Indication

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • 5.3. Cancer
    • 5.3.1. Global Lipid Nanoparticle Raw Materials Market, by Cancer, by Region, 2019-2032 (USD Million)
  • 5.4. Infectious Diseases
    • 5.4.1. Global Lipid Nanoparticle Raw Materials Market, by Infectious Diseases, by Region, 2019-2032 (USD Million)
  • 5.5. Blood Diseases
    • 5.5.1. Global Lipid Nanoparticle Raw Materials Market, by Blood Diseases, by Region, 2019-2032 (USD Million)
  • 5.6. Others
    • 5.6.1. Global Lipid Nanoparticle Raw Materials Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Lipid Nanoparticle Raw Materials Market, by Product

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • 6.3. Ionizable lipids
    • 6.3.1. Global Lipid Nanoparticle Raw Materials Market, by Ionizable lipids, by Region, 2019-2032 (USD Million)
  • 6.4. Reagents
    • 6.4.1. Global Lipid Nanoparticle Raw Materials Market, by Reagents, by Region, 2019-2032 (USD Million)
  • 6.5. Other raw materials
    • 6.5.1. Global Lipid Nanoparticle Raw Materials Market, by Other raw materials, by Region, 2019-2032 (USD Million)

7. Global Lipid Nanoparticle Raw Materials Market, by Application

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • 7.3. Therapeutics
    • 7.3.1. Global Lipid Nanoparticle Raw Materials Market, by Therapeutics, By Region, 2019-2032 (USD Million)
  • 7.4. Research
    • 7.4.1. Global Lipid Nanoparticle Raw Materials Market, by Research, By Region, 2019-2032 (USD Million)

8. Global Lipid Nanoparticle Raw Materials Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Lipid Nanoparticle Raw Materials Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Lipid Nanoparticle Raw Materials Market - North America
    • 8.3.1. North America: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
    • 8.3.2. North America: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
    • 8.3.3. North America: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.3.4. Lipid Nanoparticle Raw Materials Market - U.S.
      • 8.3.4.1. U.S.: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.3.5. Lipid Nanoparticle Raw Materials Market - Canada
      • 8.3.5.1. Canada: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • 8.4. Lipid Nanoparticle Raw Materials Market - Europe
    • 8.4.1. Europe: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
    • 8.4.3. Europe: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.4.4. Lipid Nanoparticle Raw Materials Market - UK
      • 8.4.4.1. UK: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.4.4.3. UK: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.4.5. Lipid Nanoparticle Raw Materials Market - France
      • 8.4.5.1. France: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.4.5.3. France: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.4.6. Lipid Nanoparticle Raw Materials Market - Germany
      • 8.4.6.1. Germany: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.4.7. Lipid Nanoparticle Raw Materials Market - Italy
      • 8.4.7.1. Italy: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.4.8. Lipid Nanoparticle Raw Materials Market - Spain
      • 8.4.8.1. Spain: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.4.9. Lipid Nanoparticle Raw Materials Market - Netherlands
      • 8.4.9.1. Netherlands: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.4.10. Lipid Nanoparticle Raw Materials Market - Russia
      • 8.4.10.1. Russia: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • 8.5. Lipid Nanoparticle Raw Materials Market - Asia Pacific
    • 8.5.1. Asia Pacific: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.5.4. Lipid Nanoparticle Raw Materials Market - China
      • 8.5.4.1. China: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.5.4.3. China: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.5.5. Lipid Nanoparticle Raw Materials Market - India
      • 8.5.5.1. India: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.5.5.3. India: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.5.6. Lipid Nanoparticle Raw Materials Market - Malaysia
      • 8.5.6.1. Malaysia: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.5.7. Lipid Nanoparticle Raw Materials Market - Japan
      • 8.5.7.1. Japan: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.5.8. Lipid Nanoparticle Raw Materials Market - Indonesia
      • 8.5.8.1. Indonesia: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.5.9. Lipid Nanoparticle Raw Materials Market - South Korea
      • 8.5.9.1. South Korea: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • 8.6. Lipid Nanoparticle Raw Materials Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.6.4. Lipid Nanoparticle Raw Materials Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.6.5. Lipid Nanoparticle Raw Materials Market - UAE
      • 8.6.5.1. UAE: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.6.6. Lipid Nanoparticle Raw Materials Market - Israel
      • 8.6.6.1. Israel: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.6.7. Lipid Nanoparticle Raw Materials Market - South Africa
      • 8.6.7.1. South Africa: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • 8.7. Lipid Nanoparticle Raw Materials Market - Latin America
    • 8.7.1. Latin America: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
    • 8.7.3. Latin America: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.7.4. Lipid Nanoparticle Raw Materials Market - Mexico
      • 8.7.4.1. Mexico: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.7.5. Lipid Nanoparticle Raw Materials Market - Brazil
      • 8.7.5.1. Brazil: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.7.6. Lipid Nanoparticle Raw Materials Market - Argentina
      • 8.7.6.1. Argentina: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Avanti Polar Lipids (US)
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. .Biopharma PEG Scientific Inc. (US)
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. BroadPharm (US)
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. CordenPharma International (Germany)
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Creative Biolabs (US)
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Echelon Biosciences (US)
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Merck KGaA (Germany)
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. NOF AMERICA CORPORATION (US)
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Polysciences, Inc. (US)
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Tebu Bio (France)
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development